Truist Securities Maintains Hold on Hims & Hers Health, Lowers Price Target to $10
Portfolio Pulse from jenniferd'souza@benzinga.com
Truist Securities analyst Jailendra Singh has maintained a 'Hold' rating on Hims & Hers Health (NYSE:HIMS) and lowered the price target from $12 to $10.
August 09, 2023 | 2:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a 'Hold' rating on Hims & Hers Health and lowered the price target from $12 to $10.
The lowering of the price target by Truist Securities from $12 to $10 indicates a bearish outlook for Hims & Hers Health. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100